Hacker News Reader

Comment by alphaoverlord | Hacker News Reader

It’s a research dataset, similar to MNIST or CIFAR. Stanford does not want to be in the business of monetizing patient data, so it restricts commercial use.

View on HN

You just stated a paradox like it makes sense. If you _didn’t_ want to be in the business of monetizing data, while providing data, you _wouldn’t_ restrict commercial use.

how broad is the non commercial use clause? I can imagine i.e. some BigPharma buying another datasets and using your data sets for who knows, validation of the acquired ones/metadata improvement etc. No commercial product in the area of imaging/diagnosis but maybe some commercial drug 10-15 years down the road. Do you think that such use is also forbidden by the licence?

The datasets are deidentified, so that doesn't seem like a plausible rationale

The issue of monetizing is completely separate to de-identification.

Often sources of this type of medical data will give them to universities under the no-commerical-use condition.

The reason they do this is so that they can later monetize the dataset.

Often, no.

It's because if they charge for it the admin of having to pass money back to participating people is prohibitive.

Often you can't buy these datasets at any price.

Just look at how agitated people here are getting at the prospect of GitHub copilot using tiny code snippets from their work for potentially commercial works.

Then imagine it’s not your unique way to loop over a file in python, but your medical information.

Reply on news.ycombinator.com